ArticleCureus2025
Trends and Predictors of Re-excision Following Breast-Conserving Surgery: A Decade-Long Retrospective Study in Saudi Arabia.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBreast-conserving surgery (BCS) is a widely used alternative to mastectomy for early-stage breast cancer. Achieving clear surgical margins is critical to reducing local recurrence, but re-excision is sometimes required, potentially delaying adjuvant therapy and affecting outcomes. Data on trends, predictors, and implications of re-excision in Saudi Arabia are limited.
methodsWe conducted a retrospective cohort study of 1,248 women who underwent BCS for invasive breast cancer or ductal carcinoma in situ at tertiary hospitals in the Eastern Province from 2015 to 2024. Patient demographics, tumor characteristics, surgical details, margin status, and adjuvant therapy timelines were collected. The primary outcome was re-excision, defined as any subsequent breast operation to achieve negative margins. Univariable and multivariable logistic regression analyses were performed to identify predictors of re-excision. Temporal trends in re-excision rates and time to adjuvant therapy were analyzed.
resultsThe median patient age was 54 years (interquartile range (IQR): 46-63), and invasive ductal carcinoma was the most common histology (78.6%). Overall, 181 (14.5%) patients underwent re-excision, with rates declining from 18.6% in 2015 to 11.2% in 2024. Positive margin status at the index surgery was the strongest predictor of re-excision (adjusted odds ratio (OR): 4.52; 95% confidence interval (CI): 3.15-6.47). Other independent predictors included younger age (<45 years; OR: 1.82), lobular histology (OR: 1.94), tumor size > 2 cm (OR: 1.73), and multifocal disease (OR: 2.06). Preoperative MRI was associated with reduced odds of re-excision (OR: 0.66). Median time from index surgery to final margin clearance was 18 days for patients undergoing re-excision. Delays in radiotherapy beyond eight weeks occurred in 41.6% of re-excised patients versus 19.3% without re-excision (P<0.001). Three-year local recurrence did not differ significantly between groups (4.1% versus 2.7%; P=0.11).
conclusionsRe-excision rates after BCS in Saudi Arabia have declined over the past decade. Positive margin status, younger age, lobular histology, larger tumors, and multifocal disease remain key risk factors. Re-excision is associated with delays in adjuvant radiotherapy, highlighting the importance of strategies to minimize repeat surgery while ensuring oncologic safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.